Harvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...

Tata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...

Given the fluctuating situation in the Gulf region because of the US-Iran conflict, there is no guarantee that the market will not fall fur...

Uttar Pradesh Chief Minister Yogi Adityanath reviewed health and medical education. He stressed improving treatment quality and expanding s...

As nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...

It also a 177% increase in gross margins with total losses reducing by 31% compared to the previous fiscal year. Additionally, the percenta...

The drug will target specific genetic mutations prevalent in certain types of cancers, paving the way for a more tailored and effective tre...

Super-speciality medicines play an indispensable role in addressing complex health issues, but they often remain ensnared in a web of acces...

This launch will ensure that the patients and caregivers across India have access to over 5,000 speciality medicines.

"The berry-bearing black nightshade shrub is proving to possess the potency to treat liver cancer, as the compound, Uttroside-B isolated fr...

MedGenome plans to use the funds raised to expand clinical genomic testing to India's tier-2 and tier-3 towns and cities, as well as toward...

It is important to nurture and support such indigenous innovation in these early days - as they can make India the MedTech innovation hub f...

Called PrimaMed, the 600-bed facility is coming up on Golf Course Road and will mark the entry of Nayati Healthcare, which is promoted by N...

The round also saw participation from Zodius Capital, former Infosys CEO Kris Gopalakrishnan and former Cognizant CEO Lakshmi Narayanan.

MedGenome has seen the number of samples triple for genetic tests in of samples triple for genetic tests in the last one year.

Medical devices sector in India needs to be regulated in harmonisation with international practises, trade association AdvaMed has said.

Scientists have uncovered the molecular basis of fibroadenoma, one of the most common benign breast tumours diagnosed in women of reproduct...